GAMCO Investors’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

GAMCO Investors’s Portfolio ORTX Stock Details ORTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-15,188	Closed	-$250K	–	889
2023 Q4	$250K	Buy	+15,188	New	+$239K	﹤0.01%	778

GAMCO Investors's ORTX Position: Q1 2024 in Review

GAMCO Investors sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q1 2024, closing a stake of 15,188 shares — an estimated $250K sold.

GAMCO Investors first reported a position in ORTX in Q4 2023 and held it in 1 quarter. The position peaked at $250K in Q4 2023. 0 funds tracked by Wall St. Rank hold ORTX as of Q1 2024.

GAMCO Investors reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q1 2024 after selling out during the quarter.
GAMCO Investors sold 15,188 Orchard Therapeutics plc American Depositary Shares shares in Q1 2024, an estimated $250K.
GAMCO Investors first reported a position in Orchard Therapeutics plc American Depositary Shares in Q4 2023 and held it in 1 quarter.
GAMCO Investors's Orchard Therapeutics plc American Depositary Shares position peaked at $250K in Q4 2023.
0 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q1 2024.

Based on GAMCO Investors's 13F filing for Q1 2024, filed 14 May 2024.